EO in Your Inbox
Get the latest product news, special offers and research/insights from our expert team.
Get product, dose and use guidance based on your inputs and ongoing feedback. Message our clinician-led team anytime.
You also get up to 20% off all the products in your plan. Today, tomorrow and forever.
Create Your Plan NowChronic or acute pain, joint pain, nerve pain/neuropathy, migraines or recurring headaches.
After 1 week, 53% of adults 50+ saw meaningful pain improvement.
After 4 weeks, 74% of adults 50+ saw meaningful pain improvement.
Difficulty falling/staying asleep, waking through the night or poor sleep from pain, stress or medication effects.
After 1 week, 71% of adults 50+ slept meaningfully better.
After 4 weeks, 81% of adults 50+ slept meaningfully better.
Nausea, decreased appetite and difficulty eating from chemotherapy, other meds, illness, or unexplained causes.
After 1 week, 63% of cancer patients saw meaningful nausea improvement.
After 4 weeks, 92% of cancer patients saw meaningful nausea improvement.
Situational and anticipatory anxiety, worry, tension and mood disruption related to a health journey, life change or event.
After 1 week, 76% of patients saw meaningful anxiety improvement.
After 4 weeks, 82% of patients saw meaningful anxiety improvement.
"Meaningful improvement" means a 3-point or greater reduction on a validated, statistically significant (p < 0.05) PROMIS T-score. Pain and sleep figures are from adults 50+. Nausea figures are from cancer patients. Anxiety figures are from all patients. Observational data, not a randomized trial.
Start Your Plan



A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.

A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.



An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.

An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.



A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.

A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
Not satisfied after 30 days? No problem. Email us at returns@eo.care and we’ll refund your money.
EO is recommended by clinicians at leading healthcare centers, including Mayo Clinic, Mount Sinai Hospital, Northwell Health, Penn Medicine and UVA Health - as well as by leading older adult and cancer advocacy organizations.





Get the latest product news, special offers and research/insights from our expert team.